ebomi
Colour theme
Sign in
Insider · CIK 0001249675

Perceptive Life Sciences Master Fund Ltd

CIK 0001249675 Name as filed on the most recent filing

Filed as Perceptive Life Sciences Master Fund Ltd (318)

817 transaction lines · from 318 filings · filed 2003-08-08 to 2025-11-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-03-05 P, Open-market purchase Amicus Therapeutics IncFOLD 4,553,814, acquired Open Form 4 filing 0001012975-18-000267
2018-03-02 P, Open-market purchase Amicus Therapeutics IncFOLD 1,389,500, acquired Open Form 4 filing 0001012975-18-000258
2018-03-01 P, Open-market purchase Amicus Therapeutics IncFOLD 1,369,000, acquired Open Form 4 filing 0001012975-18-000253
2018-02-16 P, Open-market purchase Motus GI Holdings, Inc.MOTS 5,000,000, acquired Open Form 4 filing 0001012975-18-000220
2018-02-15 P, Open-market purchase LA Jolla Pharmaceutical CoLJPC 1,621,000, acquired Open Form 4 filing 0001012975-18-000214
2018-02-14 P, Open-market purchase Motus GI Holdings, Inc.MOTS 50,000, acquired Open Form 4 filing 0000899243-19-001412
2018-02-14 P, Open-market purchase LA Jolla Pharmaceutical CoLJPC 3,269,000, acquired Open Form 4 filing 0001012975-18-000199
2018-02-13 P, Open-market purchase LA Jolla Pharmaceutical CoLJPC 2,456,250, acquired Open Form 4 filing 0001012975-18-000199
2018-01-30 P, Open-market purchase Solid Biosciences Inc.SLDB 2 lines 16,546,520, acquired Open Form 4 filing 0001012975-18-000098
2018-01-25 P, Open-market purchase Albireo Pharma, Inc.ALBO 9,075,000, acquired Open Form 4 filing 0001012975-18-000091
2018-01-18 P, Open-market purchase Corium International, Inc.CORI 3,968,000, acquired Open Form 4 filing 0001012975-18-000080
2018-01-17 P, Open-market purchase Corium International, Inc.CORI 1,831,716, acquired Open Form 4 filing 0001012975-18-000080
2018-01-16 P, Open-market purchase Corium International, Inc.CORI 595,641, acquired Open Form 4 filing 0001012975-18-000080
2017-12-19 P, Open-market purchase Global Blood Therapeutics, Inc.GBT 6,650,000, acquired Open Form 4 filing 0001012975-17-000943
2017-10-26 P, Open-market purchase VBI Vaccines Inc/BCVBIV 9,455,000, acquired Open Form 4 filing 0001012975-17-000792
2017-10-03 P, Open-market purchase Zogenix, Inc.ZGNX 11,250,000, acquired Open Form 4 filing 0001012975-17-000735
2017-09-29 P, Open-market purchase Zogenix, Inc.ZGNX 11 lines 7,290,059, acquired Open Form 4 filing 0001012975-17-000731
2017-09-22 S, Open-market sale Versartis, Inc.VSAR 5 lines 5,281,750, disposed Open Form 4 filing 0001012975-17-000714
2017-09-21 S, Open-market sale Versartis, Inc.VSAR 2 lines 1,731,802, disposed Open Form 4 filing 0001012975-17-000714
2017-09-19 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 1,450,000, acquired Open Form 4 filing 0001012975-17-000710
2017-07-13 P, Open-market purchase Amicus Therapeutics IncFOLD 18,375,000, acquired Open Form 4 filing 0001012975-17-000540
2017-06-30 P, Open-market purchase Zogenix, Inc.ZGNX 2,538,186, acquired Open Form 4 filing 0001012975-17-000524
2017-06-30 P, Open-market purchase Corium International, Inc.CORI 2,319,236, acquired Open Form 4 filing 0001012975-17-000522
2017-06-30 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 1,361,632, acquired Open Form 4 filing 0001012975-17-000526
2017-06-19 S, Open-market sale Acelrx Pharmaceuticals IncACRX 2,100,000, disposed Open Form 4 filing 0001012975-17-000494
2017-05-25 P, Open-market purchase Corium International, Inc.CORI 11,890,000, acquired Open Form 4 filing 0001019056-17-000509
2017-02-14 P, Open-market purchase Aldeyra Therapeutics, Inc.ALDX 4,018,613, acquired Open Form 4 filing 0001019056-17-000215
2017-02-13 P, Open-market purchase Versartis, Inc.VSAR 917,425, acquired Open Form 4 filing 0001019056-17-000292
2017-02-13 P, Open-market purchase Versartis, Inc.VSAR 917,425, acquired Open Form 4 filing 0001019056-17-000140
2017-02-10 P, Open-market purchase Versartis, Inc.VSAR 521,281, acquired Open Form 4 filing 0001019056-17-000292
2017-02-10 P, Open-market purchase Versartis, Inc.VSAR 521,281, acquired Open Form 4 filing 0001019056-17-000140
2017-02-09 P, Open-market purchase Versartis, Inc.VSAR 587,928, acquired Open Form 4 filing 0001019056-17-000115
2017-02-08 P, Open-market purchase Versartis, Inc.VSAR 1,413,319, acquired Open Form 4 filing 0001019056-17-000115
2016-12-30 P, Open-market purchase Versartis, Inc.VSAR 1,041,641, acquired Open Form 4 filing 0001019056-17-000008

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. PERCEPTIVE LIFE SCIENCES MASTER FUND LTD, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001249675

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.